Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-005315-10-IT
EUCTR2006-005315-10-IT
Active, not recruiting
Not Applicable

Evaluation of safety and efficacy on visual acuity outcome of intravitreal somministration of Bevacizumab in patients with diabetic retinopathy - ND

OSPEDALE SACRO CUORE-DON CALABRIA0 sitesNovember 10, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetic RetinopathyMedDRA version: 8.1Level: LLTClassification code 10012689Term: Diabetic retinopathy
DrugsAVASTIN

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Retinopathy
Sponsor
OSPEDALE SACRO CUORE-DON CALABRIA
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
OSPEDALE SACRO CUORE-DON CALABRIA

Eligibility Criteria

Inclusion Criteria

  • •a Patients with macular edema who did not respond to laser treatment or with visual acuity 2/10 b Patients with severe diabetic retinal proliferation
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •a Poor Blood Pressure control. b Previus Thromboembolic events, myocardial infarction, cerebral stroke. c Pregnant women, or fertile age women who do not take contraceptive pills. d Breast feeding women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - NDSubfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatmentsMedDRA version: 6.1Level: PTClassification code 10060823
EUCTR2006-002424-42-ITOSPEDALE SACRO CUORE-DON CALABRIA150
Not yet recruiting
Not Applicable
Clinical trial for visual function and safety evaluation:Artificial posterior capsule construction surgery and Intraocular lens implantation with 10-0 Polypropylene surgical suture which have been used for Scleral suture fixation of intraocular lensesaphakia
JPRN-UMIN000015145Yamaguchi university hospitalophthalmology20
Completed
Phase 2
Safety and effects on visual function of 0.01% atropine eye drops for myopia Inhibition in children and adolescentsH52.5Disorders of accommodation
DRKS00020585niversitätsklinikum TübingenTübingen28
Recruiting
Phase 1
A study to see the surgical outcomes and how safe and effective is the new laser machine MEL 90Health Condition 1: null- Patients with Myopia, Hypermetropia and Astigmatism undergoing treatment on the MEL 90 excimer laser platform
CTRI/2014/09/005061ETHRADHAMA SUPERSPECIALITY EYE HOSPITA100
Active, not recruiting
Phase 1
Safety and effects on visual function of 0.01% Atropin eye drops for inhibition of nearsightedness in children and adolescenceMyopiaTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2017-002588-17-DEniversitätsklinikum Tübingen30